Literature DB >> 3954410

The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.

B Ridell, J H Olafsson, G Roupe, B Swolin, G Granerus, S Rödjer, L Enerbäck.   

Abstract

The bone marrow sections from five normal subjects and 18 patients with mastocytosis were examined to establish criteria to distinguish urticaria pigmentosa from systemic mastocytosis. Nine patients had increased numbers of mast cells in bone marrow sections stained with a long toluidine blue staining technique specific for mast cells, whereas five patients exhibited increased numbers of mast cells on May-Grünwald-Giemsa-stained smears of bone marrow. A positive correlation between the number of mast cells in sections of the bone marrow and the urinary excretion of the main histamine metabolite tele-methylimidazoleacetic acid was found. In ten of the examined bone marrow specimens, focal lesions containing mast cells, lymphocytes, and eosinophils appeared. The presence of these focal lesions together with either an increased number of mast cells in bone marrow sections and/or increased urinary excretion of telemethylimidazoleacetic acid is considered diagnostic of systemic mastocytosis. No patient exhibited myeloproliferative condition or other major hematologic abnormality.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954410

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

1.  Paediatric mastocytosis.

Authors:  M C Carter; D D Metcalfe
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

2.  Mastocytosis and Sjögren's syndrome.

Authors:  D J Bac; M van Marwijk Kooy
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Systemic mastocytosis, an unusual cause of osteoporosis.

Authors:  P Schoenaers; L S De Clerck; U Timmermans; W J Stevens
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.